CBRE vs FBRX · P/E 43, rev $40.55B vs $360.2M cap
CBRE Group Inc Class A (CBRE) versus Forte Biosciences Inc (FBRX) — a side-by-side from cached financials, not a winner call.
CBRE Group Inc Class A (CBRE) is a real estate services company listed on US.
Forte Biosciences Inc (FBRX) is a biotechnology company listed on NASDAQ.
Latest reported CBRE revenue for 2025-12-31 was $40.55B. Net income was $1.16B. CBRE currently screens at market cap $41.66B and trailing P/E 42.7.
FBRX does not have a complete income-statement cache yet.
CBRE currently screens at market cap $41.66B and trailing P/E 42.7. FBRX currently screens at market cap $360.2M.
Not investment advice. Open the CBRE and FBRX stock pages for the full models.
Not investment advice.